T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$1.82B |
| 2 |
Sea Limited
SE
|
+$1.38B |
| 3 |
Cisco
CSCO
|
+$1.16B |
| 4 |
Netflix
NFLX
|
+$1.14B |
| 5 |
Ingersoll Rand
IR
|
+$1.03B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.54B |
| 2 |
Amazon
AMZN
|
+$1.75B |
| 3 |
Amphenol
APH
|
+$1.65B |
| 4 |
KLA
KLAC
|
+$1.5B |
| 5 |
Xcel Energy
XEL
|
+$1.38B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.6% |
| 2 | Financials | 11.17% |
| 3 | Healthcare | 11.1% |
| 4 | Communication Services | 10.25% |
| 5 | Consumer Discretionary | 10.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
HealthStream
HSTM
$863M
| $612K | ﹤0.01% |
29,536
+4,239
| +17% | +$90.3K |
|
2352
Ethan Allen Interiors
ETD
$600M
| $611K | ﹤0.01% |
27,433
+3,178
| +13% | +$73.9K |
|
2353
Allient
ALNT
$1.34B
| $609K | ﹤0.01% |
10,293
+1,848
| +22% | +$116K |
|
2354
Business First Bancshares
BFST
$1.05B
| $609K | ﹤0.01% |
22,517
+6,281
| +39% | +$172K |
|
|
GRDN
2355
Guardian Pharmacy Services
GRDN
$2.6B
| $609K | ﹤0.01% |
16,164
+4,279
| +36% | +$140K |
|
2356
Butterfly Network
BFLY
$1.86B
| $605K | ﹤0.01% |
149,538
+33,143
| +28% | +$128K |
|
2357
SITE Centers
SITC
$236M
| $605K | ﹤0.01% |
111,947
+11,527
| +11% | +$70.7K |
|
2358
Excelerate Energy
EE
$1.19B
| $603K | ﹤0.01% |
18,030
+4,458
| +33% | +$160K |
|
2359
Sana Biotechnology
SANA
$882M
| $598K | ﹤0.01% |
207,492
-558,995
| -73% | -$2.2M |
|
2360
BlackSky Technology
BKSY
$843M
| $597K | ﹤0.01% |
23,720
+4,973
| +27% | +$119K |
|
2361
iRadimed
IRMD
$1.2B
| $596K | ﹤0.01% |
6,184
+1,402
| +29% | +$140K |
|
2362
LSI Industries
LYTS
$834M
| $594K | ﹤0.01% |
31,901
+4,640
| +17% | +$95.7K |
|
2363
Manitowoc
MTW
$491M
| $594K | ﹤0.01% |
50,982
+2,803
| +6% | +$37.6K |
|
|
KALV
2364
DELISTED
KalVista Pharmaceuticals
KALV
| $592K | ﹤0.01% |
29,367
+6,249
| +27% | +$101K |
|
|
XRN
2365
Chiron Real Estate Inc
XRN
$535M
| $591K | ﹤0.01% |
17,846
+2,489
| +16% | +$87.5K |
|
|
BLSH
2366
Bullish
BLSH
$3.31B
| $589K | ﹤0.01% |
16,459
+1,280
| +8% | +$44.9K |
|
2367
Aclaris Therapeutics
ACRS
$715M
| $588K | ﹤0.01% |
156,725
+16,558
| +12% | +$55.9K |
|
2368
Covenant Logistics
CVLG
$1.04B
| $588K | ﹤0.01% |
21,624
+3,919
| +22% | +$105K |
|
2369
OraSure Technologies
OSUR
$273M
| $588K | ﹤0.01% |
195,769
+12,484
| +7% | +$35.6K |
|
|
PKST
2370
DELISTED
Peakstone Realty Trust
PKST
| $586K | ﹤0.01% |
28,034
+6,155
| +28% | +$115K |
|
|
GOOD
2371
Gladstone Commercial Corp
GOOD
$623M
| $584K | ﹤0.01% |
51,020
-7,193
| -12% | -$84.4K |
|
2372
Phathom Pharmaceuticals
PHAT
$928M
| $583K | ﹤0.01% |
52,453
+15,382
| +41% | +$194K |
|
2373
Geron
GERN
$898M
| $582K | ﹤0.01% |
390,016
+77,989
| +25% | +$119K |
|
2374
Franklin Covey
FC
$239M
| $581K | ﹤0.01% |
36,786
+2,268
| +7% | +$37.3K |
|
2375
Invesco S&P 500 Equal Weight ETF
RSP
$97.3B
| $579K | ﹤0.01% |
+3,014
| New | +$597K |
|
Similar funds
T. Rowe Price Associates's Q1 2026 Portfolio in Review
As of Q1 2026, T. Rowe Price Associates held 3,202 positions worth $865B, down 6.7% from $927B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
T. Rowe Price Associates's Q1 2026 filing shows 115 new, 2,022 increased, 804 reduced and 71 closed positions. Its largest new stake was Cenovus Energy: 23,907,299 shares worth $634M. The largest sale was Microsoft, an estimated $3.54B.
By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q1 2026 buy was Cenovus Energy: 23,907,299 shares worth $634M.
- T. Rowe Price Associates added most to Advanced Micro Devices in Q1 2026, an estimated $1.82B increase.
- T. Rowe Price Associates's biggest Q1 2026 reduction was Microsoft, cutting an estimated $3.54B.
- T. Rowe Price Associates fully exited CyberArk in Q1 2026, selling an estimated $251M.
- T. Rowe Price Associates's ten largest holdings make up 34% of its $865B portfolio in Q1 2026.
- T. Rowe Price Associates opened 115 new positions and closed 71 in Q1 2026.
- T. Rowe Price Associates's portfolio value fell 6.7% quarter-over-quarter to $865B.
Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.